10/8/2009SFDA approves Sinobiopharma's Gabexate Mesylate as Pharmaceutical Raw ...

10/8/2009IMS revises global pharma market growth upwards to 4% to 6% in 2010

10/7/2009More Chinese companies tempted to introduce natural medicines to the U...

10/7/2009TPRI licenses first-to-copy drug to Yangtze River Pharma

10/7/2009Sihuan Pharma to be delisted from SGX with MBO

10/7/2009Biostar receives Chinese patent for hepatitis drug

10/7/2009GSK enters into another vaccine joint venture in China

10/7/2009Charles River Shanghai Facility Receives AAALAC, CCAC and SLAC Accredi...

10/7/2009EU targets SA, Noratis and TEVA in new wave of antitrust enforcements ...

10/7/2009Upcoming Event: Clinical Trial Magnifier Conference 2009

10/6/2009Encouraging Signs at the Initiation of Healthcare Reform

10/6/2009Sandoz launches first biosimilar in Japan

10/5/2009NDRC issues retail guidance prices for national essential drugs

10/5/2009Growth of Chinese pharma industry slowed slightly in the first eight m...

10/5/2009Chinese government conditionally approves Pfizer-Wyeth merger

10/5/2009UICC establishes China Liason Office in Tianjin

10/5/2009Sinovac receives second order for H1N1 vaccine from the Chinese govern...

10/5/2009Chinese delegation visit Cambridge to forge natural drug research link...

10/5/2009New report: innovative drug R&D on the rise in China

10/5/2009Tianyin Pharma appoints new COO

10/4/2009Nicholas Hall reports continued growth of OTC VMS market in China

10/3/2009Quintiles expects to double its Asian business in five to ten years

9/28/2009Latest developments on China's essential drug policies and implementat...

9/28/2009SFDA seeks public comments on its draft revision to the GMP regulation...

9/28/2009Shenzhen strives to become the largest flu vaccine manufacturing cente...

9/28/2009Chi-Med files another class I anticancer new drug with SFDA

9/28/2009New report predicts skyrocketing medical costs for osteoporosis in Chi...

9/28/2009CEHCA reports sharply rising prevalence of Alzheimer's Disease

9/28/2009TaiGen Biotech reports positive phase I outcome of TG-0054

9/28/2009New report: Chinese breast cancer market to nearly double in five year...

Page:647/776 Total number of articles:23279: [First][<<] [645] [646] [647] [648] [649] [>>] [End]